J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vassiloyanakopoulos, A.
Right arrow Articles by Michalopoulos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vassiloyanakopoulos, A.
Right arrow Articles by Michalopoulos, A.
Agricola
Right arrow Articles by Vassiloyanakopoulos, A.
Right arrow Articles by Michalopoulos, A.
J Med Microbiol 55 (2006), 635-638; DOI: 10.1099/jmm.0.46398-0
© 2006 Society for General Microbiology
ISSN 1473-5644

Case Report

Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user

Antonios Vassiloyanakopoulos1, Matthew E. Falagas1,2,3, Maria Allamani4 and Argyris Michalopoulos2,5

1 ,4 ,5 Department of Medicine1 , Pathology Department4 and Intensive Care Unit5 , Henry Dunant Hospital, Athens, Greece

2 Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece

3 Department of Medicine, Tufts University School of Medicine, Boston, MA, USA

Correspondence
Argyris Michalopoulos
amichalopoulos{at}hol.gr

Received 3 November 2005
Accepted 30 December 2005

Invasive aspergillosis is an emerging infection mainly affecting immunocompromised patients. This report details a case of Aspergillus fumigatus tricuspid native valve endocarditis complicated by recurrent septic pulmonary emboli in a young, non-intravenous drug user. He was treated by surgical resection of the posterior leaflet of the tricuspid valve and the vegetations, as well as by valvuloplasty, which was followed by a combination of liposomal amphotericin B and voriconazole as acute-phase therapy and voriconazole alone as suppression therapy.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.